IBD—with its two main clinical entities ulcerative colitis and Crohn's disease—is one of the most frequent gastrointestinal diseases in the developed world, placing a large burden on health-care services, and also has increasing incidence in developing countries. Although IBD is incurable, multiple drugs are available for the management of symptoms. IBD can develop rapidly in individuals of any age, from young children to older people in their sixties and seventies. Clinical research findings now indicate that the characteristics of the disease vary according to the age at disease onset and so specific management approaches are required depending on when IBD develops. This Focus issue brings together leaders in the field to provide new insights into the protection of mothers and babies during pregnancy and/or lactation, management of paediatric patients, how best to coordinate the transition of patients from a paediatrician to a gastroenterologist during adolescence, as well as how to diagnose and manage elderly-onset IBD.



Reviews

IBD across the age spectrum—is it the same disease?

Joannie Ruel, Darren Ruane, Saurabh Mehandru, Corinne Gower-Rousseau & Jean-Frédéric Colombel

doi:10.1038/nrgastro.2013.240

Nature Reviews Gastroenterology & Hepatology 11, 88-98 (2014)

IBD is a chronic disorder with disease onset ranging from early childhood to beyond the sixth decade of life. This Review provides an overview of the differences in epidemiology, clinical characteristics, and natural history of paediatric, adult, and elderly-onset IBD. In addition, potential differences in host–gene–microbial interactions according to age are highlighted.

Advances in the medical management of paediatric IBD

Marina Aloi, Federica Nuti, Laura Stronati & Salvatore Cucchiara

doi:10.1038/nrgastro.2013.158

Nature Reviews Gastroenterology & Hepatology 11, 99-108 (2014)

Paediatric IBD often presents with a more severe phenotype and course than adult-onset disease. Here, the current knowledge concerning treatment options for children with IBD are reported. The effectiveness and safety of new therapeutic advances, including biologic agents, in these paediatric patients are also discussed.

Transition of management in adolescents with IBD

Bella Zeisler & Jeffrey S. Hyams

doi:10.1038/nrgastro.2013.254

Nature Reviews Gastroenterology & Hepatology 11, 109-115 (2014)

Transition of adolescents and young adults with IBD from paediatric to adult-focused health-care systems can be difficult, and care is needed to avoid breaks in continuity of care and negative effects on patient health. Here, Zeisler and Hyams provide a comprehensive overview of transitional care in paediatric IBD.

IBD medications during pregnancy and lactation

Ole Haagen Nielsen, Cynthia Maxwell & Jakob Hendel

doi:10.1038/nrgastro.2013.135

Nature Reviews Gastroenterology & Hepatology 11, 116-127 (2014)

IBD often affects patients during their peak reproductive years. In this Review, the authors summarize the latest information concerning the safety of medications used to treat IBD during pregnancy and lactation, as well as their effect on fertility.

Clinical implications of ageing for the management of IBD

Christina Y. Ha & Seymour Katz

doi:10.1038/nrgastro.2013.241

Nature Reviews Gastroenterology & Hepatology 11, 128-138 (2014)

Factors associated with ageing, such as comorbidities, polypharmacy and diminished physical reserve, can affect the natural history of IBD. This Review highlights how these age-associated variables can affect older patients with IBD and also illustrates the multiple gaps in our current knowledge of IBD in the elderly.

Top

Extra navigation

natureevents

Advertisement